Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma

Background: Traditionally, the treatment options for unresectable locally advanced (UR-LA) and metastatic (UR-M) pancreatic ductal adenocarcinoma (PDAC) are palliative chemotherapy or chemoradiotherapy. The benefits of surgery for such patients remains unknown. The present study investigated clinica...

Full description

Bibliographic Details
Main Authors: Hiroaki Yanagimoto, Sohei Satoi, Tomohisa Yamamoto, So Yamaki, Satoshi Hirooka, Masaya Kotsuka, Hironori Ryota, Mitsuaki Ishida, Yoichi Matsui, Mitsugu Sekimoto
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
unresectable pancreatic ductal adenocarcinoma
conversion surgery
early recurrence
Online Access:https://www.mdpi.com/2072-6694/12/6/1428

Internet

https://www.mdpi.com/2072-6694/12/6/1428

Similar Items